Background The US Food and Drug Administration requires six text-only warnings for cigar products, including cigarillos. Research has demonstrated the superiority of pictorial over text-only cigarette warnings, yet the relative effectiveness of pictorial warnings for cigarillos has not been examined. We examined the impact of pictorial cigarillo warnings compared with text-only warnings.
Methods Data were collected from a nationally representative sample of US young adult (18–29) cigarillo users and susceptible non-users. Participants were randomised to one of three experimental conditions: text-only or one of two pictorial conditions (combined for analyses). For each warning, we assessed negative emotional reactions, cognitive elaboration (ie, thinking about cigarillo risks) and perceived message effectiveness (PME).
Results Participants (N=661) were 46.5% female, 64.7% white and 21.9% Hispanic; 34.1% reported past 30-day cigarillo use; 41.4% were lifetime users (excluding past 30-day use); and 24.4% were susceptible non-users. Pictorial warnings elicited more negative emotional reactions and higher PME than text-only warnings (p values<0.01), with interactions showing the largest effects for past 30-day users (emotional reactions: d=0.99, PME: d=0.63). For cognitive elaboration, there was no main effect of warning type, but an interaction revealed effects for past 30-day users (p<0.05, d=0.46).
Conclusions Pictorial cigarillo warnings elicited greater negative emotional reactions and PME compared with text-only warnings. These effects and the effects on cognitive elaboration were strongest for past 30-day users. Our findings extend research on cigarette warnings to cigarillos, demonstrating that pictorial warnings are superior to text-only warnings for cigarillos in eliciting beneficial responses.
- packaging and labelling
- non-cigarette tobacco products
- public policy
Data availability statement
No data are available. Additional data are currently being analysed.
Statistics from Altmetric.com
Twitter @jencornacc, @AllisonLazard, @jess4817, @SethNoar, @desmondjenson, @erinsutfin
Contributors JCR led the study design; AJL developed study stimuli; and BAR performed the statistical analyses. All authors contributed to the implementation of the study, writing and revision of the manuscript, and approval of the final version of the manuscript.
Funding Research reported in this article was supported by the National Cancer Institute and Food and Drug Administration (FDA) Center for Tobacco Products (award number R03CA206487). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the FDA.
Competing interests SMN has served as a paid expert witness in government litigation against tobacco companies. There are no additional competing interests.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.